Troubled infant formula plant resumes production

Identification of a therapeutic target for the treatment of lymphoma
11 July 2022
Stress testing can help determine which patients are likely to benefit from heart procedures to improve survival
11 July 2022

Troubled infant formula plant resumes production

Abbott Inc. has announced that it has resumed production at its infant formula plant, following a February shutdown over contamination concerns that triggered a months-long shortage of infant formula.

Comments are closed.